DePuy ATTUNE(r) Knee
A DePuy ATTUNE(r), or Attune(r) knee, is a medical device that has caused several injuries in patients who have received it. This product was introduced by DePuy Synthes, a subsidiary of Johnson & Johnson, in 2010. The device was marketed as offering an improved range of motion, stability, and confidence in knee replacement surgery. Unfortunately, thousands of people have undergone revision surgery after experiencing complications with their new knees.
Although the company claims that the Attune knee replacement system is safe and effective, the FDA has yet to formally recall any of these devices. This is in part due to the high rate of tibial loosening, but there are other issues, including defects in the surgical instrumentation. A deplorable defect in the tibial articulation surface instruments may lead to dislocation, infection, or even death.
DePuy SIGMA HP PFJ Cemented Trochlear Implants
The high revision rates of the Sigma HP PFJ cemented trochlear implant, a component of the Sigma knee system, led to a massive recall. The defect was the cause of instability, malalignment, and joint alignment problems, which DePuy acknowledged in a December 2017 safety warning. The company subsequently recalled the device and is now looking into the potential for further recalls.
According to the DePuy SIGMA HP PDJ recalled device, the Sigma HP PFJ cemented trochlear implant is not made of solid titanium. Patients may experience unnatural sliding of the implant, resulting in dislocation. A Class II Device Recall was initiated in 2015 to address the issue. This recall impacted over 3,000 units of the implant.
DePuy LPS Diaphyseal Sleeve
A lawsuit against the manufacturer of the DePuy LPS Diaphysial Sleeve knee implant is currently under investigation by Parker Waichman LLP, a law firm dedicated to protecting the rights of individuals harmed by faulty medical devices. The DePuy LPS Diaphyseal Sleeve is a component of the LPS System, which is a knee reconstruction device recalled by the U.S. Food and Drug Administration. Its use in reconstructive knee surgery has caused several serious side effects, including fractures and soft tissue damage.
A lawsuit filed against DePuy relates to the LPS Diaphyseal Sleeve, a component used in knee replacement surgery to help improve the fit of a patient’s femur. Approximately 10,000 people have filed a DePuy LPS Diaphyseal Sleeve lawsuit, and the company has been notified of more than ten separate incidents of implant failure.
Zimmer NexGen Implant
The DePuy and Zimmer NexGen Knee LPS litigation are one of the most significant litigations in orthopedic surgery today. Both companies were accused of manufacturing dangerous knee implants. Zimmer’s legal defense argues that the defect in the knee replacement caused the patient’s injury. The jury agreed, but Joas argued that the manufacturer had no duty to warn about the risk of the Zimmer NexGen knee replacement.
A lawsuit claiming defective products or injuries caused by defective medical devices can be filed in nearly every state, including the U.S. The Zimmer NexGen knee replacement lawsuit aims to recover compensation for the pain, suffering, and emotional distress incurred by its patients. The law firm will evaluate your case and determine the best strategy to pursue your compensation claim. A qualified medical device attorney will listen to your story and determine the best compensation strategy.
A jury has decided that the manufacturer of a Zimmer Biomet Knee LPS implant failed to adequately warn a surgeon of its risks. Joas, who is a physician, filed a lawsuit against Zimmer and DePuy for alleged injuries caused by the device. Ultimately, the jury found for Zimmer, but the company is appealing the decision. This is an important step in a lawsuit against a manufacturer of knee replacement devices.
The company is trying to get its manufacturing facility to recall the defective implants. The lawsuit is against Zimmer Biomet, a company that manufactures hip and knee replacements. The company is accused of infringing on patents by other companies. According to the complaint, Zimmer Biomet has a pattern of infringing on these patents and is therefore liable for the pain and suffering of its patients.